drugset / Trial / NCT00553020

Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes

NCT00553020 ↗

Phase 4 Completed 16 enrolled Sanofi
RandomizedCrossoverSingle-blindTreatment

Summary

To assess the duration of the metabolic effect of a sc injected single dose of either insulin glargine (LantusT) or NPH-insulin (ProtaphanT) on blood glucose control in patients with type 2 diabetes

Timeline

Start
2004-04
Primary completion
—
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic 0.3 iu/kg Subcutaneous